5
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Phage Group, Lipase Activity and Protein a Content of Staphylococcus Aureus Strains from Cases of Chronic Osteomyelitis

&
Pages 203-207 | Published online: 02 Jan 2015
 

Abstract

61 patients with chronic osteomyelitis were admitted to the University Hospital of Lund during a 7-year period. Positive cultures were obtained from 59 cases, all of them showing growth of Staphylococcus aureus. 50 strains were phage-typed, 40 strains tested for lipase activity, and 16 strains investigated on protein A content and α-toxin production. The osteomyelitic strains were compared in these respects and regarding antibiotic resistance patterns with other staphylococcal strains from routine diagnostic work. 13/15 strains from cases of hematogenous osteomyelitis belonged to phage groups I and II; none belonged to group III. This distribution differed significantly from posttraumatic osteomyelitic strains and from strains isolated from cases of septicemia. 90% of the osteomyelitic strains were lipase-positive and did not differ from unselected strains. Among the unselected control strains lipase activity in phage group III was significantly less frequent than in phage groups I and II. All 16 osteomyelitic strains tested were protein A-positive. The incidence of α-toxin production in osteomyelitic strains did not differ from that in the control strains.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.